Literature DB >> 30281844

Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa.

Yali Wu1,2, Jian Qu1, Huabing Li3, Haiyan Yuan1, Qi Guo4, Zhanbo Ouyang1, Qiong Lu1.   

Abstract

BACKGROUND: Adolescents with anorexia nervosa (AN) have low body mass and low bone mineral density (BMD). Growth differentiation factor 8 (Myostatin, GDF8) and its homologue growth differentiation factor 11 (GDF11), members of the TGF-β super-family, play an important role in muscle regeneration and bone metabolism in healthy individuals. However, their association with BMD in AN is unknown. The present study was undertaken to investigate the relationship between GDF8, GDF11 and BMD in adolescent girls with AN.
METHODS: Serum GDF8, GDF11 and BMD were determined in 25 girls (12-16 years old) with AN and 31 healthy girls (12-16 years old).
RESULTS: Growth differentiation factor 8 levels were lower in AN subjects. On the contrary, GDF11 levels were higher in AN subjects than controls. There was no relationship between GDF8 and BMD. A significant negative correlation between GDF11 and BMD was found. In multiple linear stepwise regression analysis, BMI, 25-hydroxyvitamin D, GDF11, or lean mass, but not fat mass and GDF8, were independent predictors of BMD in the AN and control groups separately.
CONCLUSIONS: Growth differentiation factor 11 was independent predictor of BMD in girls with AN. It suggested that GDF11 exerts a negative effect on bone mass.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  anorexia nervosa; bone mineral density; growth differentiation factor 11; growth differentiation factor 8

Mesh:

Substances:

Year:  2018        PMID: 30281844     DOI: 10.1111/cen.13871

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alteration.

Authors:  Laurent Maïmoun; Denis Mariano-Goulart; Helena Huguet; Eric Renard; Patrick Lefebvre; Marie-Christine Picot; Anne-Marie Dupuy; Jean-Paul Cristol; Philippe Courtet; Vincent Boudousq; Antoine Avignon; Sébastien Guillaume; Ariane Sultan
Journal:  Endocr Connect       Date:  2022-05-10       Impact factor: 3.221

2.  Growth differentiation factor 11 inhibits adipogenic differentiation by activating TGF-beta/Smad signalling pathway.

Authors:  Hongke Luo; Yuchen Guo; Yuting Liu; Yuan Wang; Rixin Zheng; Yu Ban; Lin Peng; Quan Yuan; Weiqing Liu
Journal:  Cell Prolif       Date:  2019-04-30       Impact factor: 6.831

Review 3.  Body composition in anorexia nervosa: Meta-analysis and meta-regression of cross-sectional and longitudinal studies.

Authors:  Christopher Hübel; Zeynep Yilmaz; Katherine E Schaumberg; Lauren Breithaupt; Avina Hunjan; Eleanor Horne; Judit García-González; Paul F O'Reilly; Cynthia M Bulik; Gerome Breen
Journal:  Int J Eat Disord       Date:  2019-09-12       Impact factor: 4.861

4.  Modification of Muscle-Related Hormones in Women with Obesity: Potential Impact on Bone Metabolism.

Authors:  Laurent Maïmoun; Thibault Mura; Vincent Attalin; Anne Marie Dupuy; Jean-Paul Cristol; Antoine Avignon; Denis Mariano-Goulart; Ariane Sultan
Journal:  J Clin Med       Date:  2020-04-17       Impact factor: 4.241

Review 5.  Deciphering Myostatin's Regulatory, Metabolic, and Developmental Influence in Skeletal Diseases.

Authors:  Catherine L Omosule; Charlotte L Phillips
Journal:  Front Genet       Date:  2021-03-29       Impact factor: 4.599

Review 6.  Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps.

Authors:  Jan Baczek; Marta Silkiewicz; Zyta Beata Wojszel
Journal:  Nutrients       Date:  2020-08-11       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.